Richter I - Search Results

1

The prognostic significance of tumor epidermal growth factor receptor (EGFR) expression change after neoadjuvant chemoradiation in patients with rectal adenocarcinoma.

Richter I, Dvořák J, Urbanec M, Bluml A, Čermáková E, Bartoš J, Petera J. Richter I, et al. Contemp Oncol (Pozn). 2015;19(1):48-53. doi: 10.5114/wo.2015.50013. Epub 2015 Mar 26. Contemp Oncol (Pozn). 2015. PMID: 26199571 Free PMC article.

2

The changes of tumour vascular endothelial growth factor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma.

Buka D, Dvorak J, Sitorova V, Sirak I, Voboril R, Melichar B, Richter I. Buka D, et al. Among authors: richter i. Contemp Oncol (Pozn). 2017;21(1):48-53. doi: 10.5114/wo.2017.66656. Epub 2017 Mar 22. Contemp Oncol (Pozn). 2017. PMID: 28435398 Free PMC article.

3

The prognostic effect of neoadjuvant chemoradiotherapy on the change of PD-L1 expression in patients with locally advanced rectal adenocarcinoma.

Richter I, Jirasek T, Dvorak J, Cermakova E, Rehakova P, Bartos J. Richter I, et al. J BUON. 2017 Jul-Aug;22(4):875-881. J BUON. 2017. PMID: 29155514 Free article.

4

The expression of PD-L1 in patients with castrate prostate cancer treated with enzalutamide.

Richter I, Jirasek T, Havlickova I, Curcikova R, Samal V, Dvorak J, Bartos J. Richter I, et al. J BUON. 2018 Nov-Dec;23(6):1796-1802. J BUON. 2018. PMID: 30610805 Free article.

5

Prognostic significance of changes of tumor epidermal growth factor receptor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma.

Dvorak J, Sitorova V, Ryska A, Sirak I, Richter I, Hatlova J, Ferko A, Melichar B, Petera J. Dvorak J, et al. Among authors: richter i. Strahlenther Onkol. 2012 Sep;188(9):833-8. doi: 10.1007/s00066-012-0160-x. Epub 2012 Aug 1. Strahlenther Onkol. 2012. PMID: 22847519 Clinical Trial.

6

[The combination of neoadjuvant chemoradiotherapy and epidermal growth factor receptor inhibitors in the treatment of rectal adenocarcinoma].

Richter I, Dvořák J, Bartoš J. Richter I, et al. Klin Onkol. 2014;27(3):166-72. doi: 10.14735/amko2014166. Klin Onkol. 2014. PMID: 24918274 Czech.

7

[Influence of preoperative chemoradiotherapy on changes of epidermal growth factor receptor expression in patients treated by preoperative chemoradiotherapy for local advanced rectal carcinoma].

Richter I, Dvořák J, Blüml A, Cermáková E, Bartoš J, Urbanec M, Sitorová V, Ryška A, Sirák I, Buka D, Ferko A, Melichar B, Petera J. Richter I, et al. Klin Onkol. 2014;27(5):361-6. doi: 10.14735/amko2014361. Klin Onkol. 2014. PMID: 25312714 Czech.

8

The prognostic significance of epidermal growth factor receptor expression in patients with anal carcinoma.

Richter I, Jirasek T, Dvorak J, Cermakova E, Bartos J. Richter I, et al. Neoplasma. 2016;63(3):435-41. doi: 10.4149/313_150913N485. Neoplasma. 2016. PMID: 26925790

9

Patients with metastatic renal cell carcinoma treated with cabozantinib in the Czech Republic: analysis of four cancer centers.

Richter I, Poprach A, Zemankova A, Buchler T, Bartos J, Samal V, Studentova H, Rozsypalova A, Dvorak J, Brom O, Melichar B. Richter I, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022 Mar;166(1):97-104. doi: 10.5507/bp.2020.055. Epub 2020 Nov 26. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022. PMID: 33252116 Free article.

10

[The Possibility of Epidermal Growth Factor Receptor Inhibition in Anal Cancer].

Richter I, Dvořák J, Jirásek T, Bartoš J. Richter I, et al. Klin Onkol. 2015;28(4):260-4. doi: 10.14735/amko2015260. Klin Onkol. 2015. PMID: 26299739 Czech.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

290 results

Search Page

Filters